Sarah Bétrian

8PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 06, 2026
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial.

Isabelle Ray-Coquard, Marie-Christine Kaminsky-Forrett, Ryotaro Ohkuma

|Aug 08, 2024
Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy.

Violeta Romero, Martina Aida Angeles, Elena Rodríguez González

|Mar 12, 2024
Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer.

Mathilde Del, Claire Illac, Mathilde Morisseau

|Apr 19, 2023
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud

|Nov 29, 2022
Impact of pattern of recurrence on post-relapse survival according to surgical timing in patients with advanced ovarian cancer.

Martina Aida Angeles, Emanuela Spagnolo, Bastien Cabarrou

|Jul 20, 2022
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer.

Sarah Betrian, Martina Aida Angeles, Antonio Gil Moreno

Pageof 2

Frequent Collaborators

5 joint publications

Alejandra Martinez

4 joint publications

Martina Aida Angeles

3 joint publications

Agnieszka Rychlik

3 joint publications

Gwenael Ferron